Vandenbroek MD - Search Results

1

Efficacy and tolerance of 200 mg micronised fenofibrate administered over a 6-month period in hyperlipidaemic patients: an open Belgian multicenter study.

Kornitzer M, Dramaix M, Vandenbroek MD, Everaert L, Gerlinger C. Kornitzer M, et al. Among authors: vandenbroek md. Atherosclerosis. 1994 Oct;110 Suppl:S49-54. doi: 10.1016/0021-9150(94)05378-v. Atherosclerosis. 1994. PMID: 7857385 Clinical Trial.

2

Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.

Leyvraz PF, Bachmann F, Hoek J, Büller HR, Postel M, Samama M, Vandenbroek MD. Leyvraz PF, et al. Among authors: vandenbroek md. BMJ. 1991 Sep 7;303(6802):543-8. doi: 10.1136/bmj.303.6802.543. BMJ. 1991. PMID: 1655136 Free PMC article. Clinical Trial.

3

[Combination of lys-plasminogen and urokinase in subpopliteal acute ischemia. Preliminary results].

Girand C, Tasrini J, Joffre F, Vandenbroek MD, Cerene A. Girand C, et al. Among authors: vandenbroek md. Presse Med. 1985 Feb 9;14(5):281-2. Presse Med. 1985. PMID: 3157112 French. No abstract available.

4

[Indications and results of combined urokinase-lys plasminogen in acute ischemic pathology of the legs].

Giraud C, Joffre F, Tasrini J, Carrie JM, Vandenbroek MD, Puel P, Cerene A. Giraud C, et al. Among authors: vandenbroek md. J Mal Vasc. 1985;10(4):321-6. J Mal Vasc. 1985. PMID: 4093720 French.

5

Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial.

Petitpretz P, Simmoneau G, Cerrina J, Musset D, Dreyfus M, Vandenbroek MD, Duroux P. Petitpretz P, et al. Among authors: vandenbroek md. Circulation. 1984 Nov;70(5):861-6. doi: 10.1161/01.cir.70.5.861. Circulation. 1984. PMID: 6488499

6

[Local low-dose thrombolytic treatment with sequential urokinase-plasminogen in deep central venous thrombosis].

Robert D, Fournel P, Holzapfel L, Mercatello A, Guérin C, Vandenbroek MD. Robert D, et al. Among authors: vandenbroek md. Rev Med Interne. 1984 Sep;5(3):263-7. doi: 10.1016/s0248-8663(84)80067-3. Rev Med Interne. 1984. PMID: 6505433 French.

7

[Present status of the regulation of physiological fibrinolysis. Therapeutic prospects of lys-plasminogen].

Vandenbroek MD, Bordes B. Vandenbroek MD, et al. Rev Med Interne. 1984 Sep;5(3):251-4. doi: 10.1016/s0248-8663(84)80065-x. Rev Med Interne. 1984. PMID: 6505431 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters